Treatment of Peyronie's Disease

 


Specific treatment for Peyronie's disease will be determined by your physician based on your:

  • Age, overall health, and medical history
  • Extent of the disease
  • Tolerance for specific medications, procedures, or therapies
  • Expectations for the course of the disease
  • Opinion or preference

In general, the goal of treatment is to keep the patient with Peyronie's disease sexually active. Providing education about the disease and its course is often included in the treatment plan. In some cases, treatment is not necessary, as Peyronie's disease often occurs in a mild form that heals without treatment in 6 to 15 months.

Treatment may include:

  • Prescribing or continuing palliative methods
  • Surgery
  • Vitamin E - small studies have reported improvements with oral vitamin E prescribed by a physician. However, larger controlled studies have not been completed to establish the effectiveness of this treatment
  • Injections of various chemical agents into plaque - have been used in a small number of patients, and for this reason, this intervention is considered unproven. Unwanted side effects may occur
  • Radiation Therapy - with this treatment approach, radiation is aimed at the plaque to reduce pain, but does not affect the plaque itself; unwanted side effects or worsening of the disease may occur.

 

Latest Urology News
Prostate cancer radiotherapy safe for HIV patients

December 1, 2008 — NEW YORK (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected men. Treatment appears to have no long-term effect on CD4+ cell count or viral load.

Drug proves useful in hard-to-treat BPH: study

November 28, 2008 — NEW YORK (Reuters Health) - In men with an enlarged prostate who fail to respond to tamsulosin (brand name Flomax), treatment with the drug naftopidil may help alleviate common bothersome symptoms, such as having to make frequent nightly trips to the bathroom to urinate, research shows.

Cancer rates and cancer-related deaths drop in U.S.

November 25, 2008 — NEW YORK (Reuters Health) - For the first time ever, the overall cancer incidence and death rates have declined for men and women in the United States, according to an annual report released Tuesday by the American Cancer Society, the National Cancer Institute, and other groups.

Select news items provided by Reuters Health